See which stocks are pulling investors into the conversation, what the crowd is saying, and whether the attention is broad or concentrated.
Top stocks by X chatter · rolling 1-day window
Azitra reportedly pauses its ATM program and shares ex vivo results for ATR-COSF. The company is said to have halted dilution efforts amid high trading volume following the announcement.
Research →Prime Medicine reportedly dosed its first patient in a gene editing trial on October 5. Concurrently, data indicates a recent volume spike was not driven by short covering, with short interest remaining high at 32.8 million shares.
Research →Open any ticker to investigate the catalyst, price action, filings, earnings, news, positioning, and risks.